AAAAAA

   
Results: 1-7 |
Results: 7
TAMOXIFEN AS PRIMARY THERAPY IN COMBINED-MODALITY TREATMENT OF ELDERLY PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER
Authors: VALERO V HOFF P SINGLETARY ES BUZDAR AU BOOSER DJ ASMAR L MCNEESE M HORTOBAGYI GN
Citation: V. Valero et al., TAMOXIFEN AS PRIMARY THERAPY IN COMBINED-MODALITY TREATMENT OF ELDERLY PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 78-78
ADJUVANT ANTHRACYCLINE-CONTAINING THERAPY IN WOMEN GREATER-THAN-OR-EQUAL-TO-65 YEARS WITH BREAST-CANCER - THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE
Authors: VALERO V BUZDAR AU ASMAR L THERIAULT RL BOOSER DJ MCNEESE M SINGLETARY SE HORTOBAGYI GN
Citation: V. Valero et al., ADJUVANT ANTHRACYCLINE-CONTAINING THERAPY IN WOMEN GREATER-THAN-OR-EQUAL-TO-65 YEARS WITH BREAST-CANCER - THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE, Annals of oncology, 9, 1998, pp. 144-144
A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER
Authors: VALERO V JONES SE VONHOFF DD BOOSER DJ MENNEL RG RAVDIN PM HOLMES FA RAHMAN Z SCHOTTSTAEDT MW ERBAN JK ESPARZAGUERRA L EARHART RH HORTOBAGYI GN BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368
SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HOLMES FA MADDEN T NEWMAN RA VALERO V THERIAULT RL FRASCHINI G WALTERS RS BOOSER DJ BUZDAR AU WILLEY J HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON (RIFN-ALPHA) AND CONTINUOUS-INFUSION 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
Authors: WALTERS RS THERIAULT RL BOOSER DJ ESPARZA L HORTOBAGYI GN
Citation: Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON (RIFN-ALPHA) AND CONTINUOUS-INFUSION 5-FLUOROURACIL IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 185-187
BIOEQUIVALENCE OF 20-MG ONCE-DAILY TAMOXIFEN RELATIVE TO 10-MG TWICE-DAILY TAMOXIFEN REGIMENS FOR BREAST-CANCER
Authors: BUZDAR AU HORTOBAGYI GN FRYE D HO D BOOSER DJ VALERO V HOLMES FA BIRMINGHAM BK BUI K YEH C PLOURDE PV
Citation: Au. Buzdar et al., BIOEQUIVALENCE OF 20-MG ONCE-DAILY TAMOXIFEN RELATIVE TO 10-MG TWICE-DAILY TAMOXIFEN REGIMENS FOR BREAST-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 50-54
ANTHRACYCLINE ANTIBIOTICS IN CANCER-THERAPY - FOCUS ON DRUG-RESISTANCE
Authors: BOOSER DJ HORTOBAGYI GN
Citation: Dj. Booser et Gn. Hortobagyi, ANTHRACYCLINE ANTIBIOTICS IN CANCER-THERAPY - FOCUS ON DRUG-RESISTANCE, Drugs, 47(2), 1994, pp. 223-258
Risultati: 1-7 |